Cardiac Myosin Binding Protein-C Phosphorylation Mitigates Age-Related Cardiac Dysfunction

Autor: Jerome P. Trzeciakowski, R. John Solaro, Paola C Rosas, Heidi A. Creed, Chad M. Warren, Carl W. Tong
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Cardiac function curve
lcsh:Diseases of the circulatory (Cardiovascular) system
medicine.medical_specialty
Diastole
heart failure
HFpEF
heart failure with preserved ejection fraction

macromolecular substances
cMyBP-C
cardiac myosin binding protein-C

030204 cardiovascular system & hematology
HF
heart failure

cTnI
cardiac troponin I

Muscle hypertrophy
Cardiac dysfunction
3SA
mutated 3 serines to 3 alanines to mimic hypophosphorylated cardiac myosin binding protein-C (S273A
S282A
and S302A)

HOP
hydroxyproline

03 medical and health sciences
PRECLINICAL RESEARCH
0302 clinical medicine
Internal medicine
medicine
EF
ejection fraction

Papillary muscle
LV
left ventricular

ANOVA
analysis of variance

cardiac myosin binding protein-C
business.industry
dyastolic dysfunction
phosphorylation
Binding protein
aging
3SD
mutated 3 serines to 3 aspartic acids to mimic phosphorylated cMyBP-C (S273D
S282D
and S302D)

medicine.disease
030104 developmental biology
medicine.anatomical_structure
Endocrinology
lcsh:RC666-701
Heart failure
Phosphorylation
Cardiology and Cardiovascular Medicine
business
Zdroj: JACC: Basic to Translational Science
JACC: Basic to Translational Science, Vol 4, Iss 7, Pp 817-830 (2019)
ISSN: 2452-302X
Popis: Visual Abstract
Highlights • With aging, phosphorylated-mimetic cMyBP-C mice exhibited better survival, better preservation of systolic and diastolic functions, and unchanging wall thickness compared with control mice. • Aged wild-type equivalent mice exhibited decreasing cMyBP-C phosphorylation (S273 and S282) along with worsening cardiac function and hypertrophy similarly to what was observed in hypophosphorylated cMyBP-C mice. • Intact papillary muscle experiments suggest that cMyBP-C phosphorylation increased cross-bridge detachment rates as the underlying mechanism. • Phosphorylating cMyBP-C is therefore a novel mechanism that can prevent aging-related development of cardiac dysfunction.
Summary Cardiac myosin binding protein-C (cMyBP-C) phosphorylation prevents aging-related cardiac dysfunction. We tested this hypothesis by aging genetic mouse models of hypophosphorylated cMyBP-C, wild-type equivalent, and phosphorylated-mimetic cMyBP-C for 18 to 20 months. Phosphorylated-mimetic cMyBP-C mice exhibited better survival, better preservation of systolic and diastolic functions, and unchanging wall thickness. Wild-type equivalent mice showed decreasing cMyBP-C phosphorylation along with worsening cardiac function and hypertrophy approaching those found in hypophosphorylated cMyBP-C mice. Intact papillary muscle experiments suggested that cMyBP-C phosphorylation increased cross-bridge detachment rates as the underlying mechanism. Thus, phosphorylating cMyBP-C is a novel mechanism with potential to treat aging-related cardiac dysfunction.
Databáze: OpenAIRE